Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Mucositis × Breast × Clear all

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Other 94 Head & Neck 43 Other hematologic neoplasm 10 Plasma cell 6 Lymphoid 6 Gastrointestinal 4 Classical hematology 3 Sarcoma 2 Genitourinary 2 Thoracic 1 Myeloid 1 CNS 1 Breast 1

Conditions

Breast Neoplasms 8535 Triple Negative Breast Neoplasms 845 Neoplasms 488 Ovarian Neoplasms 458 Neoplasm Metastasis 439 Carcinoma, Non-Small-Cell Lung 396 Colorectal Neoplasms 387 Prostatic Neoplasms 367 Lung Neoplasms 366 Pancreatic Neoplasms 267 Melanoma 249 Stomach Neoplasms 239 Breast Neoplasms, Male 225 Motor Activity 214 Colonic Neoplasms 198 Endometrial Neoplasms 189 Head and Neck Neoplasms 188 Uterine Cervical Neoplasms 186 Carcinoma, Intraductal, Noninfiltrating 177 Carcinoma, Renal Cell 157 Squamous Cell Carcinoma of Head and Neck 151 Sarcoma 151 Brain Neoplasms 138 Urinary Bladder Neoplasms 136 Esophageal Neoplasms 130 Breast Carcinoma In Situ 125 Lymphedema 121 Carcinoma, Ovarian Epithelial 117 Fatigue 114 Small Cell Lung Carcinoma 103

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06958445 2025-05-06

SAFE

Taipei City Hospital

Phase 2 Enrolling by invitation

Breast Neoplasms, Esophagitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡